Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alastair Thompson, MD
Baylor College of Medicine
Study Chair - Ann Partridge, MD, MPH
Dana-Farber Cancer Institute
Study Chair - Shelley Hwang, MD, MPH
Duke University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
141 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Mayo Clinic
Phoenix, Arizona, United States
- City of Hope
Duarte, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Sharp Memorial Hospital
San Diego, California, United States
- Kaiser Permanente Medical Center
Vallejo, California, United States
- Colorado Cancer Research Program
Denver, Colorado, United States
- Saint Joseph Hospital- Cancer Centers of Colorado
Lafayette, Colorado, United States
- Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- Memorial Healthcare System
Hollywood, Florida, United States
- Mayo Clinic Florida
Jacksonville, Florida, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Kootenai Health
Post Falls, Idaho, United States
- Advocate Illinois Masonic Medical Center
Chicago, Illinois, United States
- John H Stroger Jr Hospital of Cook County
Chicago, Illinois, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Ingalls Memorial Hospital
Harvey, Illinois, United States
- Illinois Cancer Care
Peoria, Illinois, United States
- Osf Saint Anthony Medical Center
Rockford, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- Medical Oncology and Hematology Associates - Des Moines
Des Moines, Iowa, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- University of Kansas Cancer Center
Kansas City, Kansas, United States
- St. Elizabeth Healthcare Edgewood
Edgewood, Kentucky, United States
- University of Kentucky/markey Cancer Center
Lexington, Kentucky, United States
- Mary Bird Perkins Cancer Center
Baton Rouge, Louisiana, United States
- Ochsner Medical Center Jefferson
New Orleans, Louisiana, United States
- Eastern Maine Medical Center Cancer Care
Brewer, Maine, United States
- Maine Center for Cancer Medicine-Scarborough
Scarborough, Maine, United States
- New England Cancer Specialists
Scarborough, Maine, United States
- Anne Arundel Medical Center
Annapolis, Maryland, United States
- University of Maryland - Greenebaum Comprehensive Cancer Center
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Saint Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Cancer Research Consortium of West Michigan
Grand Rapids, Michigan, United States
- Beaumont Ncorp
Royal Oak, Michigan, United States
- Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Feb 2017
- Primary completion
- 27 Jun 2024
- Completion
- 31 Jul 2030
- Last update posted
- 12 May 2026
- Registered enrollment
- 997
- Registry id
- NCT02926911
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.